» Articles » PMID: 15014502

Control of the SCF(Skp2-Cks1) Ubiquitin Ligase by the APC/C(Cdh1) Ubiquitin Ligase

Overview
Journal Nature
Specialty Science
Date 2004 Mar 12
PMID 15014502
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

Skp2 and its cofactor Cks1 are the substrate-targeting subunits of the SCF(Skp2-Cks1) (Skp1/Cul1/F-box protein) ubiquitin ligase complex that regulates entry into S phase by inducing the degradation of the cyclin-dependent kinase inhibitors p21 and p27 (ref. 1). Skp2 is an oncoprotein that often shows increased expression in human cancers; however, the mechanism that regulates its cellular abundance is not well understood. Here we show that both Skp2 and Cks1 proteins are unstable in G1 and that their degradation is mediated by the ubiquitin ligase APC/C(Cdh1) (anaphase-promoting complex/cyclosome and its activator Cdh1). Silencing of Cdh1 by RNA interference in G1 cells stabilizes Skp2 and Cks1, with a consequent increase in p21 and p27 proteolysis. Depletion of Cdh1 also increases the percentage of cells in S phase, whereas concomitant downregulation of Skp2 reverses this effect, showing that Skp2 is an essential target of APC/C(Cdh1). Expression of a stable Skp2 mutant that cannot bind APC/C(Cdh1) induces premature entry into S phase. Thus, the induction of Skp2 and Cks1 degradation in G1 represents a principal mechanism by which APC/C(Cdh1) prevents the unscheduled degradation of SCF(Skp2-Cks1) substrates and maintains the G1 state.

Citing Articles

Distinct outcomes from targeted perturbations of the multi-subunit SCF E3 ubiquitin ligase in blocking Trp53/Rb1-null prostate tumorigenesis.

Xue Y, Zhu L, Karan S, Locker J, Branch C, Zhang J Commun Biol. 2025; 8(1):278.

PMID: 39987265 PMC: 11846996. DOI: 10.1038/s42003-025-07662-3.


Single-cell analysis reveals host S phase drives large T antigen expression during BK polyomavirus infection.

Needham J, Perritt S, Thompson S PLoS Pathog. 2024; 20(12):e1012663.

PMID: 39636788 PMC: 11620372. DOI: 10.1371/journal.ppat.1012663.


APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.

Mouery B, Baker E, Mei L, Wolff S, Mills C, Fleifel D Proc Natl Acad Sci U S A. 2024; 121(30):e2319574121.

PMID: 39024113 PMC: 11287123. DOI: 10.1073/pnas.2319574121.


Enzyme-independent role of EZH2 in regulating cell cycle progression via the SKP2-KIP/CIP pathway.

Colon T, Kou Z, Choi B, Tran F, Zheng E, Dai W Sci Rep. 2024; 14(1):13389.

PMID: 38862595 PMC: 11166936. DOI: 10.1038/s41598-024-64338-4.


Targeting RCC1 to block the human soft-tissue sarcoma by disrupting nucleo-cytoplasmic trafficking of Skp2.

Zhuang M, Li F, Liang H, Su Y, Cheng L, Lin B Cell Death Dis. 2024; 15(4):241.

PMID: 38561375 PMC: 10985091. DOI: 10.1038/s41419-024-06629-2.